Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
01 January 2020 | Story Eugene Seegers | Photo Kaleidoscope Studios | Sonia Small
Kaleidoscope - Dr Maria Madiope - New South Campus Principal
Dr Maria Madiope took over the reins of the UFS South Campus at the beginning of January 2020.

The Council of the University of the Free State (UFS) approved the appointment of Dr Maria ‘Marinkie’ Madiope as Principal of the South Campus for Open Distance Learning (ODL) during a meeting held on 20 September 2019. Dr Madiope took over the reins of the UFS South Campus at the beginning of January 2020.

Educator at heart

Educating and empowering others are key aspects of Dr Madiope's life. She has served as the Director for University Teaching and Learning at Unisa since 2015 and takes her role incredibly seriously, achieving a transformative curriculum at the colleges under her care since her appointment.

Dr Madiope holds a PhD in Education from Unisa, with a specialisation in Didactics; her next two degrees where completed at the then RAU, which is today known as the University of Johannesburg: a BEd in 1999, followed by an MEd in 2001, both specialising in Computer-based Instruction. She previously obtained her BA Ed in 1985 and a BEd in 1988 from the University of the North. Her initial training as a teacher was from the Hebron College of Education from 1980-81.

Dr Madiope is also the editor of the only journal in ODL, Progressio, since 2016. Her expertise in E-learning is another of her strong points. Together with her team, Dr Madiope designed and developed the first online course in Curriculum Transformation, which is being piloted at Unisa. Her work has been rewarded with awards such as the Unisa Gender Activism: Advocacy and Promotion of Women’s Rights 2013, Unisa Woman of the Year 2013, and Unisa Best Performer 2013.

Dr Madiope brings with her a wealth of experience to UFS and her vision is to increase access to a wider base of learners with potentially having more African learners enrolled. The first point of call would be to have more learners coming from Lesotho and then the rest of the SADEC region, having the UFS become a leading distance-learning university. One of the key projects that Dr Madiope wishes to tackle is early childhood development. “I believe in educating educators to ensure that they are best equipped to provide the latest and relevant Early childhood and development practices that are on par with the rest of the world,” she says.

Community leader

In addition to being an experienced educator and administrator, Dr Madiope is instrumental in community projects that lie close to her heart. Whether it is large-scale advocacy for women’s rights or her personal involvement in the supply of sanitary towels for schoolgirls as part of a programme to empower the girl child through exposing them to options, it is humbling to watch her compassion in action.

She further intends to strengthen the relationship of the university with TVET Colleges and community colleges by providing mutually beneficial programmes that will up-skill those colleagues by giving them an opportunity to work with experienced UFS staff members. She says, “Reaching out to colleagues in TVET and Community colleges will offer them the opportunity to advance their lecturing and learning programmes, which will only lead to benefiting their learners and South Africa as a whole.”

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept